SCHEMBL6441328

SCHEMBL6441328

O=C(NCc1cccs1)Oc1ccc(F)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.46
CYP3A4 P08684 3/20 0.41
CYP2D6 P10635 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2B6 P20813 1/20 0.41
KCNH2 Q12809 1/20 0.41
HPGD P15428 4/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 2/20 0.38
NPC1 O15118 1/20 0.38
MAPK10 P53779 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 2/20 0.35
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6442987 0.89 CYP2C9 (0.49) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6445354 0.86 CYP2C9 (0.50) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6446934 0.86 ALDH1A1 (0.49) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6442104 0.84 CYP2C9 (0.53) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6440978 0.83 CYP2C9 (0.54) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6442418 0.83 CYP2C9 (0.51) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6444101 0.83 CYP2C9 (0.56) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6443286 0.83 CYP2C9 (0.49) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6442978 0.83 CYP2C9 (0.51) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL6445721 0.82 CYP2C9 (0.45) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299382-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2005-09-21 EP claimed